nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—CARTPT—acquired immunodeficiency syndrome	0.577	1	CbGaD
Amphetamine—SLC22A3—Lamivudine—acquired immunodeficiency syndrome	0.0567	0.208	CbGbCtD
Amphetamine—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.0527	0.193	CbGbCtD
Amphetamine—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0346	0.127	CbGbCtD
Amphetamine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0176	0.0645	CbGbCtD
Amphetamine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0166	0.0607	CbGbCtD
Amphetamine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0166	0.0607	CbGbCtD
Amphetamine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.015	0.0549	CbGbCtD
Amphetamine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.015	0.0549	CbGbCtD
Amphetamine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0129	0.0474	CbGbCtD
Amphetamine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0125	0.046	CbGbCtD
Amphetamine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0113	0.0416	CbGbCtD
Amphetamine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0113	0.0416	CbGbCtD
Amphetamine—CARTPT—nerve—acquired immunodeficiency syndrome	0.00522	0.112	CbGeAlD
Amphetamine—CARTPT—blood plasma—acquired immunodeficiency syndrome	0.00395	0.0846	CbGeAlD
Amphetamine—CARTPT—lymphoid tissue—acquired immunodeficiency syndrome	0.00154	0.0329	CbGeAlD
Amphetamine—CARTPT—blood—acquired immunodeficiency syndrome	0.00145	0.031	CbGeAlD
Amphetamine—CARTPT—spinal cord—acquired immunodeficiency syndrome	0.00139	0.0298	CbGeAlD
Amphetamine—SLC6A3—nerve—acquired immunodeficiency syndrome	0.00134	0.0287	CbGeAlD
Amphetamine—SLC18A2—blood plasma—acquired immunodeficiency syndrome	0.00134	0.0287	CbGeAlD
Amphetamine—L-Phenylalanine—TAT—acquired immunodeficiency syndrome	0.00129	0.553	CrCbGaD
Amphetamine—TAAR1—lung—acquired immunodeficiency syndrome	0.00127	0.0272	CbGeAlD
Amphetamine—CARTPT—nervous system—acquired immunodeficiency syndrome	0.00118	0.0251	CbGeAlD
Amphetamine—TAAR1—nervous system—acquired immunodeficiency syndrome	0.00118	0.0251	CbGeAlD
Amphetamine—MAOB—nerve—acquired immunodeficiency syndrome	0.00117	0.025	CbGeAlD
Amphetamine—TAAR1—central nervous system—acquired immunodeficiency syndrome	0.00113	0.0242	CbGeAlD
Amphetamine—CARTPT—central nervous system—acquired immunodeficiency syndrome	0.00113	0.0242	CbGeAlD
Amphetamine—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00108	0.0232	CbGeAlD
Amphetamine—DRD2—nerve—acquired immunodeficiency syndrome	0.000987	0.0211	CbGeAlD
Amphetamine—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.000931	0.0199	CbGeAlD
Amphetamine—CARTPT—brain—acquired immunodeficiency syndrome	0.000898	0.0192	CbGeAlD
Amphetamine—MAOB—blood plasma—acquired immunodeficiency syndrome	0.000885	0.0189	CbGeAlD
Amphetamine—CARTPT—lymph node—acquired immunodeficiency syndrome	0.000868	0.0186	CbGeAlD
Amphetamine—Pseudoephedrine—IL2—acquired immunodeficiency syndrome	0.000711	0.305	CrCbGaD
Amphetamine—SLC18A2—digestive system—acquired immunodeficiency syndrome	0.000516	0.011	CbGeAlD
Amphetamine—SLC18A2—blood—acquired immunodeficiency syndrome	0.000492	0.0105	CbGeAlD
Amphetamine—SLC18A2—vagina—acquired immunodeficiency syndrome	0.000456	0.00976	CbGeAlD
Amphetamine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000449	0.0096	CbGeAlD
Amphetamine—SLC18A2—lung—acquired immunodeficiency syndrome	0.000431	0.00923	CbGeAlD
Amphetamine—DRD2—retina—acquired immunodeficiency syndrome	0.000409	0.00875	CbGeAlD
Amphetamine—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000407	0.00871	CbGeAlD
Amphetamine—SLC18A2—nervous system—acquired immunodeficiency syndrome	0.000399	0.00854	CbGeAlD
Amphetamine—CYP2A6—lung—acquired immunodeficiency syndrome	0.000385	0.00824	CbGeAlD
Amphetamine—SLC18A2—central nervous system—acquired immunodeficiency syndrome	0.000384	0.00823	CbGeAlD
Amphetamine—SLC22A5—retina—acquired immunodeficiency syndrome	0.000381	0.00815	CbGeAlD
Amphetamine—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.000358	0.00767	CbGeAlD
Amphetamine—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000358	0.00766	CbGeAlD
Amphetamine—SLC6A4—blood—acquired immunodeficiency syndrome	0.000341	0.0073	CbGeAlD
Amphetamine—MAOB—digestive system—acquired immunodeficiency syndrome	0.00034	0.00728	CbGeAlD
Amphetamine—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.000334	0.00715	CbGeAlD
Amphetamine—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000328	0.00703	CbGeAlD
Amphetamine—SLC6A3—lung—acquired immunodeficiency syndrome	0.000326	0.00698	CbGeAlD
Amphetamine—SLC22A3—vagina—acquired immunodeficiency syndrome	0.000325	0.00695	CbGeAlD
Amphetamine—MAOB—blood—acquired immunodeficiency syndrome	0.000324	0.00694	CbGeAlD
Amphetamine—MAOB—spinal cord—acquired immunodeficiency syndrome	0.000312	0.00668	CbGeAlD
Amphetamine—SLC22A3—lung—acquired immunodeficiency syndrome	0.000307	0.00657	CbGeAlD
Amphetamine—SLC18A2—brain—acquired immunodeficiency syndrome	0.000305	0.00653	CbGeAlD
Amphetamine—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.000302	0.00646	CbGeAlD
Amphetamine—MAOB—vagina—acquired immunodeficiency syndrome	0.0003	0.00643	CbGeAlD
Amphetamine—SLC6A4—lung—acquired immunodeficiency syndrome	0.000299	0.0064	CbGeAlD
Amphetamine—SLC18A2—lymph node—acquired immunodeficiency syndrome	0.000295	0.00631	CbGeAlD
Amphetamine—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.000291	0.00622	CbGeAlD
Amphetamine—SLC22A3—nervous system—acquired immunodeficiency syndrome	0.000284	0.00609	CbGeAlD
Amphetamine—MAOB—lung—acquired immunodeficiency syndrome	0.000284	0.00608	CbGeAlD
Amphetamine—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000277	0.00592	CbGeAlD
Amphetamine—SLC22A3—central nervous system—acquired immunodeficiency syndrome	0.000274	0.00586	CbGeAlD
Amphetamine—CYP2A6—brain—acquired immunodeficiency syndrome	0.000273	0.00583	CbGeAlD
Amphetamine—SLC22A5—digestive system—acquired immunodeficiency syndrome	0.000267	0.00572	CbGeAlD
Amphetamine—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000266	0.0057	CbGeAlD
Amphetamine—MAOB—nervous system—acquired immunodeficiency syndrome	0.000263	0.00563	CbGeAlD
Amphetamine—SLC6A2—lung—acquired immunodeficiency syndrome	0.000263	0.00563	CbGeAlD
Amphetamine—SLC22A5—blood—acquired immunodeficiency syndrome	0.000255	0.00545	CbGeAlD
Amphetamine—MAOB—central nervous system—acquired immunodeficiency syndrome	0.000253	0.00542	CbGeAlD
Amphetamine—SLC22A5—spinal cord—acquired immunodeficiency syndrome	0.000245	0.00525	CbGeAlD
Amphetamine—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000244	0.00521	CbGeAlD
Amphetamine—Pseudoephedrine—TNF—acquired immunodeficiency syndrome	0.00024	0.103	CrCbGaD
Amphetamine—DRD2—lung—acquired immunodeficiency syndrome	0.00024	0.00513	CbGeAlD
Amphetamine—SLC22A5—vagina—acquired immunodeficiency syndrome	0.000236	0.00505	CbGeAlD
Amphetamine—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000235	0.00502	CbGeAlD
Amphetamine—SLC6A3—brain—acquired immunodeficiency syndrome	0.000231	0.00494	CbGeAlD
Amphetamine—SLC22A5—lung—acquired immunodeficiency syndrome	0.000223	0.00478	CbGeAlD
Amphetamine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000222	0.00475	CbGeAlD
Amphetamine—SLC22A3—brain—acquired immunodeficiency syndrome	0.000217	0.00465	CbGeAlD
Amphetamine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000214	0.00457	CbGeAlD
Amphetamine—SLC6A4—brain—acquired immunodeficiency syndrome	0.000212	0.00453	CbGeAlD
Amphetamine—SLC22A3—lymph node—acquired immunodeficiency syndrome	0.00021	0.00449	CbGeAlD
Amphetamine—MAOB—brain—acquired immunodeficiency syndrome	0.000201	0.0043	CbGeAlD
Amphetamine—MAOB—lymph node—acquired immunodeficiency syndrome	0.000194	0.00416	CbGeAlD
Amphetamine—SLC6A2—brain—acquired immunodeficiency syndrome	0.000186	0.00399	CbGeAlD
Amphetamine—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.00018	0.00385	CbGeAlD
Amphetamine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000178	0.00175	CcSEcCtD
Amphetamine—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.00175	CcSEcCtD
Amphetamine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000178	0.00175	CcSEcCtD
Amphetamine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000178	0.00175	CcSEcCtD
Amphetamine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000177	0.00175	CcSEcCtD
Amphetamine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000177	0.00175	CcSEcCtD
Amphetamine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000177	0.00174	CcSEcCtD
Amphetamine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000177	0.00174	CcSEcCtD
Amphetamine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000177	0.00174	CcSEcCtD
Amphetamine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.00174	CcSEcCtD
Amphetamine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000176	0.00174	CcSEcCtD
Amphetamine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000176	0.00174	CcSEcCtD
Amphetamine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000176	0.00173	CcSEcCtD
Amphetamine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000175	0.00173	CcSEcCtD
Amphetamine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000175	0.00172	CcSEcCtD
Amphetamine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000174	0.00172	CcSEcCtD
Amphetamine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000174	0.00171	CcSEcCtD
Amphetamine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000174	0.00171	CcSEcCtD
Amphetamine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000174	0.00171	CcSEcCtD
Amphetamine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.00171	CcSEcCtD
Amphetamine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000173	0.00171	CcSEcCtD
Amphetamine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000173	0.00369	CbGeAlD
Amphetamine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.0017	CcSEcCtD
Amphetamine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000172	0.0017	CcSEcCtD
Amphetamine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000172	0.0017	CcSEcCtD
Amphetamine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000171	0.00168	CcSEcCtD
Amphetamine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00017	0.00168	CcSEcCtD
Amphetamine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.00168	CcSEcCtD
Amphetamine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.00167	CcSEcCtD
Amphetamine—DRD2—brain—acquired immunodeficiency syndrome	0.00017	0.00363	CbGeAlD
Amphetamine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.00167	CcSEcCtD
Amphetamine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000169	0.00166	CcSEcCtD
Amphetamine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000167	0.00165	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000167	0.00165	CcSEcCtD
Amphetamine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000167	0.00165	CcSEcCtD
Amphetamine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.00164	CcSEcCtD
Amphetamine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.00164	CcSEcCtD
Amphetamine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000166	0.00164	CcSEcCtD
Amphetamine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.00164	CcSEcCtD
Amphetamine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000166	0.00164	CcSEcCtD
Amphetamine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000166	0.00164	CcSEcCtD
Amphetamine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000165	0.00163	CcSEcCtD
Amphetamine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.00162	CcSEcCtD
Amphetamine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.00162	CcSEcCtD
Amphetamine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000164	0.00162	CcSEcCtD
Amphetamine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000164	0.00352	CbGeAlD
Amphetamine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000163	0.00161	CcSEcCtD
Amphetamine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.00161	CcSEcCtD
Amphetamine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.00161	CcSEcCtD
Amphetamine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000163	0.00161	CcSEcCtD
Amphetamine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000162	0.0016	CcSEcCtD
Amphetamine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000162	0.0016	CcSEcCtD
Amphetamine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.0016	CcSEcCtD
Amphetamine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000162	0.0016	CcSEcCtD
Amphetamine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000162	0.0016	CcSEcCtD
Amphetamine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000161	0.00159	CcSEcCtD
Amphetamine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000161	0.00159	CcSEcCtD
Amphetamine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000161	0.00158	CcSEcCtD
Amphetamine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00016	0.00158	CcSEcCtD
Amphetamine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00016	0.00158	CcSEcCtD
Amphetamine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.00158	CcSEcCtD
Amphetamine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.00157	CcSEcCtD
Amphetamine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.00157	CcSEcCtD
Amphetamine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.00157	CcSEcCtD
Amphetamine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000159	0.00157	CcSEcCtD
Amphetamine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000159	0.00156	CcSEcCtD
Amphetamine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000158	0.00156	CcSEcCtD
Amphetamine—SLC22A5—brain—acquired immunodeficiency syndrome	0.000158	0.00338	CbGeAlD
Amphetamine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000158	0.00156	CcSEcCtD
Amphetamine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.00155	CcSEcCtD
Amphetamine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.00155	CcSEcCtD
Amphetamine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000157	0.00155	CcSEcCtD
Amphetamine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.00155	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000156	0.00154	CcSEcCtD
Amphetamine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000155	0.00153	CcSEcCtD
Amphetamine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.00153	CcSEcCtD
Amphetamine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.00153	CcSEcCtD
Amphetamine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000154	0.00152	CcSEcCtD
Amphetamine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000154	0.00152	CcSEcCtD
Amphetamine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000154	0.00152	CcSEcCtD
Amphetamine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.00152	CcSEcCtD
Amphetamine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.00152	CcSEcCtD
Amphetamine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.00151	CcSEcCtD
Amphetamine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000153	0.00151	CcSEcCtD
Amphetamine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000153	0.00151	CcSEcCtD
Amphetamine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000153	0.00151	CcSEcCtD
Amphetamine—SLC22A5—lymph node—acquired immunodeficiency syndrome	0.000153	0.00327	CbGeAlD
Amphetamine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000153	0.00151	CcSEcCtD
Amphetamine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000153	0.00151	CcSEcCtD
Amphetamine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.0015	CcSEcCtD
Amphetamine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.00149	CcSEcCtD
Amphetamine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.00149	CcSEcCtD
Amphetamine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.00149	CcSEcCtD
Amphetamine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00015	0.00148	CcSEcCtD
Amphetamine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.00148	CcSEcCtD
Amphetamine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.00146	CcSEcCtD
Amphetamine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.00146	CcSEcCtD
Amphetamine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000148	0.00146	CcSEcCtD
Amphetamine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000148	0.00146	CcSEcCtD
Amphetamine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000147	0.00145	CcSEcCtD
Amphetamine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.00145	CcSEcCtD
Amphetamine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.00145	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.00145	CcSEcCtD
Amphetamine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.00145	CcSEcCtD
Amphetamine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000147	0.00145	CcSEcCtD
Amphetamine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.00145	CcSEcCtD
Amphetamine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.00144	CcSEcCtD
Amphetamine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.00144	CcSEcCtD
Amphetamine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000146	0.00144	CcSEcCtD
Amphetamine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000146	0.00144	CcSEcCtD
Amphetamine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.00143	CcSEcCtD
Amphetamine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000145	0.00143	CcSEcCtD
Amphetamine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.00143	CcSEcCtD
Amphetamine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000145	0.00143	CcSEcCtD
Amphetamine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.00142	CcSEcCtD
Amphetamine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.00142	CcSEcCtD
Amphetamine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.00142	CcSEcCtD
Amphetamine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.00142	CcSEcCtD
Amphetamine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.00142	CcSEcCtD
Amphetamine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000143	0.00141	CcSEcCtD
Amphetamine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000143	0.00141	CcSEcCtD
Amphetamine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000143	0.00141	CcSEcCtD
Amphetamine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000142	0.0014	CcSEcCtD
Amphetamine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000142	0.0014	CcSEcCtD
Amphetamine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.0014	CcSEcCtD
Amphetamine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.00139	CcSEcCtD
Amphetamine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000141	0.00139	CcSEcCtD
Amphetamine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000141	0.00139	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.00139	CcSEcCtD
Amphetamine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000141	0.00139	CcSEcCtD
Amphetamine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.00139	CcSEcCtD
Amphetamine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000141	0.00139	CcSEcCtD
Amphetamine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.00138	CcSEcCtD
Amphetamine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00014	0.00138	CcSEcCtD
Amphetamine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00014	0.00138	CcSEcCtD
Amphetamine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00014	0.00138	CcSEcCtD
Amphetamine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.00137	CcSEcCtD
Amphetamine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.00137	CcSEcCtD
Amphetamine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000139	0.00137	CcSEcCtD
Amphetamine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000139	0.00137	CcSEcCtD
Amphetamine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000138	0.00137	CcSEcCtD
Amphetamine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.00137	CcSEcCtD
Amphetamine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.00136	CcSEcCtD
Amphetamine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000138	0.00136	CcSEcCtD
Amphetamine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.00136	CcSEcCtD
Amphetamine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000137	0.00135	CcSEcCtD
Amphetamine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.00134	CcSEcCtD
Amphetamine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.00133	CcSEcCtD
Amphetamine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.00133	CcSEcCtD
Amphetamine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.00133	CcSEcCtD
Amphetamine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.00133	CcSEcCtD
Amphetamine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.00132	CcSEcCtD
Amphetamine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.00132	CcSEcCtD
Amphetamine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000133	0.00286	CbGeAlD
Amphetamine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.00131	CcSEcCtD
Amphetamine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000133	0.00131	CcSEcCtD
Amphetamine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000133	0.00131	CcSEcCtD
Amphetamine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.00131	CcSEcCtD
Amphetamine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000133	0.00131	CcSEcCtD
Amphetamine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000133	0.00131	CcSEcCtD
Amphetamine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.0013	CcSEcCtD
Amphetamine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.00129	CcSEcCtD
Amphetamine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.00129	CcSEcCtD
Amphetamine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000131	0.00129	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.00128	CcSEcCtD
Amphetamine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.00128	CcSEcCtD
Amphetamine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.00128	CcSEcCtD
Amphetamine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000129	0.00128	CcSEcCtD
Amphetamine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.00128	CcSEcCtD
Amphetamine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.00127	CcSEcCtD
Amphetamine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.00127	CcSEcCtD
Amphetamine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.00127	CcSEcCtD
Amphetamine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.00127	CcSEcCtD
Amphetamine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000128	0.00275	CbGeAlD
Amphetamine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000128	0.00126	CcSEcCtD
Amphetamine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.00126	CcSEcCtD
Amphetamine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.00124	CcSEcCtD
Amphetamine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.00124	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.00124	CcSEcCtD
Amphetamine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.00123	CcSEcCtD
Amphetamine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.00123	CcSEcCtD
Amphetamine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.00122	CcSEcCtD
Amphetamine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.00122	CcSEcCtD
Amphetamine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000123	0.00122	CcSEcCtD
Amphetamine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000123	0.00122	CcSEcCtD
Amphetamine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.00122	CcSEcCtD
Amphetamine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.00121	CcSEcCtD
Amphetamine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000122	0.00121	CcSEcCtD
Amphetamine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.00121	CcSEcCtD
Amphetamine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000122	0.0012	CcSEcCtD
Amphetamine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.0012	CcSEcCtD
Amphetamine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000121	0.0012	CcSEcCtD
Amphetamine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.00119	CcSEcCtD
Amphetamine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.00118	CcSEcCtD
Amphetamine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.00118	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.00118	CcSEcCtD
Amphetamine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.00118	CcSEcCtD
Amphetamine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000119	0.00118	CcSEcCtD
Amphetamine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.00118	CcSEcCtD
Amphetamine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.00118	CcSEcCtD
Amphetamine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.00117	CcSEcCtD
Amphetamine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.00117	CcSEcCtD
Amphetamine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.00115	CcSEcCtD
Amphetamine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.00115	CcSEcCtD
Amphetamine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.00114	CcSEcCtD
Amphetamine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000115	0.00114	CcSEcCtD
Amphetamine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.00113	CcSEcCtD
Amphetamine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.00113	CcSEcCtD
Amphetamine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000115	0.00113	CcSEcCtD
Amphetamine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000114	0.00112	CcSEcCtD
Amphetamine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000114	0.00112	CcSEcCtD
Amphetamine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.00112	CcSEcCtD
Amphetamine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000113	0.00111	CcSEcCtD
Amphetamine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.00111	CcSEcCtD
Amphetamine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.0011	CcSEcCtD
Amphetamine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.0011	CcSEcCtD
Amphetamine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.00108	CcSEcCtD
Amphetamine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.00108	CcSEcCtD
Amphetamine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.00108	CcSEcCtD
Amphetamine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000108	0.00107	CcSEcCtD
Amphetamine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.00107	CcSEcCtD
Amphetamine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.00106	CcSEcCtD
Amphetamine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.00106	CcSEcCtD
Amphetamine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.00106	CcSEcCtD
Amphetamine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000107	0.00106	CcSEcCtD
Amphetamine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.00105	CcSEcCtD
Amphetamine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.00105	CcSEcCtD
Amphetamine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.00103	CcSEcCtD
Amphetamine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.00102	CcSEcCtD
Amphetamine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.00102	CcSEcCtD
Amphetamine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.00101	CcSEcCtD
Amphetamine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.00101	CcSEcCtD
Amphetamine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.00101	CcSEcCtD
Amphetamine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000102	0.00218	CbGeAlD
Amphetamine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.00101	CcSEcCtD
Amphetamine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000998	CcSEcCtD
Amphetamine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	9.97e-05	0.000983	CcSEcCtD
Amphetamine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.93e-05	0.00098	CcSEcCtD
Amphetamine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	9.93e-05	0.000979	CcSEcCtD
Amphetamine—Nausea—Delavirdine—acquired immunodeficiency syndrome	9.68e-05	0.000955	CcSEcCtD
Amphetamine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.59e-05	0.000946	CcSEcCtD
Amphetamine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.58e-05	0.000945	CcSEcCtD
Amphetamine—Rash—Ritonavir—acquired immunodeficiency syndrome	9.5e-05	0.000937	CcSEcCtD
Amphetamine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.5e-05	0.000937	CcSEcCtD
Amphetamine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	9.47e-05	0.000934	CcSEcCtD
Amphetamine—Headache—Ritonavir—acquired immunodeficiency syndrome	9.44e-05	0.000931	CcSEcCtD
Amphetamine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	9.22e-05	0.00091	CcSEcCtD
Amphetamine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	9.15e-05	0.000903	CcSEcCtD
Amphetamine—Rash—Saquinavir—acquired immunodeficiency syndrome	9.15e-05	0.000902	CcSEcCtD
Amphetamine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	9.14e-05	0.000901	CcSEcCtD
Amphetamine—Headache—Saquinavir—acquired immunodeficiency syndrome	9.09e-05	0.000897	CcSEcCtD
Amphetamine—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.95e-05	0.000883	CcSEcCtD
Amphetamine—Nateglinide—ALB—acquired immunodeficiency syndrome	8.86e-05	0.0381	CrCbGaD
Amphetamine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.8e-05	0.000868	CcSEcCtD
Amphetamine—Rash—Lamivudine—acquired immunodeficiency syndrome	8.73e-05	0.000861	CcSEcCtD
Amphetamine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.72e-05	0.00086	CcSEcCtD
Amphetamine—Headache—Lamivudine—acquired immunodeficiency syndrome	8.67e-05	0.000855	CcSEcCtD
Amphetamine—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.62e-05	0.00085	CcSEcCtD
Amphetamine—Nausea—Lamivudine—acquired immunodeficiency syndrome	8.22e-05	0.000811	CcSEcCtD
